Endoluminal therapy guading by ultrasonography or plus portosystemic shunts for Budd-Chiari syndrome: a report of 36 cases / 中国普通外科杂志

ABSTRACT

Objective To evaluate the effect of endoluminal treatment for Budd Chiari syndrome (BCS) .Methods In 36 patients with BCS were treated by inferior vena cava(IVC) dilation and endoluminal stent placement guaded by ultrasonography, including self expanding mental Giaturco stent placement in 33 patients and pure dilation in 3 patients. Portosystemic shunts(PSSs) were followed in 13 patients with hepatic venous occlusion a week after the endoluminal treatment, including splenorenal(S R) shunts in 5 cases,and mesocaval (M C) shunts in 8 cases. Results After endoluminal procedures ,slight heart dysfunction appeared in 3 cases . After shunting ,acute pancreatitis occurred in 1 case, and upper gastrointestinal hemorrhage occurred and finally resulted in death in another case on the 10th day after PSS.All the 36 patients were followed up for 1 month to 8 years. Restenosis of the distal part of stent was found in 1 case 2 years after the operation,hepatic vein occlusion occurred in 1 case 1 year after the treament, hepatoma occurred in 1case 3 years after the treatment,and 1 patient died of C type hepatitis a year later; and 2 cases with infertility had babies 1 year later. All patients had no stent migration or occlusion of shunts .Conclusions Endoluminal therapy guarding by ultrsonography is a convenient, safe and effective method for Budd Chiari syndrome. For patients with hepatic venous occlusions, a portosystemic shunt is recommended.The above mentioned methods provide a feasible and effective means for some kinds of Budd Chiari syndrome.